Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 18, 2017
Patent Application Number
14822929
Date Filed
August 11, 2015
Patent Citations Received
0
0
Patent Primary Examiner
Patent abstract
The present invention provides VEGF antagonists with improved pharmacokinetic properties. According to certain embodiments, a fusion polypeptide capable of antagonizing VEGF activity is provided comprising a modified extracellular ligand binding domain of a VEGF receptor fused to a multimerizing component.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
